Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7612713rdf:typepubmed:Citationlld:pubmed
pubmed-article:7612713lifeskim:mentionsumls-concept:C0016330lld:lifeskim
pubmed-article:7612713lifeskim:mentionsumls-concept:C0717967lld:lifeskim
pubmed-article:7612713pubmed:issue3lld:pubmed
pubmed-article:7612713pubmed:dateCreated1995-8-23lld:pubmed
pubmed-article:7612713pubmed:abstractTextThe daily contribution of F in patients subjected to TPN has been determined, based on the F content of 61 commercial solutions used to prepare the different TPN. The determinations have been done by means of a potentiometric method with and F selective electrode and a double union reference electrode. Only those commercial solutions contained in glass ampules showed traces of F, while none was detected in samples contained in plastic or other type of glass containers. In the glass ampules, the F content oscillated between 115 micrograms/l in those of 10% calcium chloride, to 931 micrograms/l in those of potassium chloride. The total contribution of F based on these preparations in TPN, does not reach 100 micrograms/day, which is much below the recommended daily dose for safety and adequacy.lld:pubmed
pubmed-article:7612713pubmed:languagespalld:pubmed
pubmed-article:7612713pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7612713pubmed:citationSubsetIMlld:pubmed
pubmed-article:7612713pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7612713pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7612713pubmed:statusMEDLINElld:pubmed
pubmed-article:7612713pubmed:issn0212-1611lld:pubmed
pubmed-article:7612713pubmed:authorpubmed-author:ChacónRRlld:pubmed
pubmed-article:7612713pubmed:authorpubmed-author:MonteroC GCGlld:pubmed
pubmed-article:7612713pubmed:authorpubmed-author:VílchezTTlld:pubmed
pubmed-article:7612713pubmed:issnTypePrintlld:pubmed
pubmed-article:7612713pubmed:volume10lld:pubmed
pubmed-article:7612713pubmed:ownerNLMlld:pubmed
pubmed-article:7612713pubmed:authorsCompleteYlld:pubmed
pubmed-article:7612713pubmed:pagination165-8lld:pubmed
pubmed-article:7612713pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7612713pubmed:meshHeadingpubmed-meshheading:7612713-...lld:pubmed
pubmed-article:7612713pubmed:meshHeadingpubmed-meshheading:7612713-...lld:pubmed
pubmed-article:7612713pubmed:meshHeadingpubmed-meshheading:7612713-...lld:pubmed
pubmed-article:7612713pubmed:meshHeadingpubmed-meshheading:7612713-...lld:pubmed
pubmed-article:7612713pubmed:meshHeadingpubmed-meshheading:7612713-...lld:pubmed
pubmed-article:7612713pubmed:meshHeadingpubmed-meshheading:7612713-...lld:pubmed
pubmed-article:7612713pubmed:articleTitle[Fluorine in parenteral nutrition solutions].lld:pubmed
pubmed-article:7612713pubmed:affiliationServicio de Farmacia, Hospital de Llerena, Badajoz, España.lld:pubmed
pubmed-article:7612713pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7612713pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:7612713pubmed:publicationTypeEnglish Abstractlld:pubmed